Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
REDWOOD CITY, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Dextera Surgical Inc. (Nasdaq:DXTR) today announced financial results for its fiscal fourth quarter and full year ended June 30, 2016. The...
-
GAAP Operating Cash Flow of $5.2 Million and Non-GAAP Free Cash Flow of $0.9 Million in the Second Quarter of 2016 GAAP Net Loss Improved $7.7 Million and Non-GAAP Adjusted EBITDA Increased from $1.4...
-
REDWOOD CITY, Calif., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (“PAD”), today...
-
EUREKA, Calif., July 29, 2016 (GLOBE NEWSWIRE) -- On July 29, 2016, REDWOOD CAPITAL BANCORP (OTCBB:RWCB), the only locally owned and operated community bank holding company in Humboldt County,...
-
REDWOOD SHORES, Calif., July 27, 2016 (GLOBE NEWSWIRE) -- Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced the...
-
REDWOOD SHORES, Calif., July 25, 2016 (GLOBE NEWSWIRE) -- Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced...
-
TORONTO, ON--(Marketwired - July 25, 2016) - Purpose Investments Inc. ("Purpose"), a leading provider of exchange traded funds ("ETFs"), mutual funds and closed-end funds, and Redwood Asset Management...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Galenica and Relypsa announce...
-
– Acquisition Strengthens Galenica’s Business Unit, Vifor Pharma – Galenica will commence a tender offer to acquire all issued and outstanding Relypsa common stock for a cash consideration of...
-
REDWOOD CITY, Calif., June 15, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that it has...